1. Home
  2. MDCX vs LTRN Comparison

MDCX vs LTRN Comparison

Compare MDCX & LTRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDCX
  • LTRN
  • Stock Information
  • Founded
  • MDCX 2008
  • LTRN 2013
  • Country
  • MDCX Canada
  • LTRN United States
  • Employees
  • MDCX N/A
  • LTRN N/A
  • Industry
  • MDCX
  • LTRN Biotechnology: Pharmaceutical Preparations
  • Sector
  • MDCX
  • LTRN Health Care
  • Exchange
  • MDCX Nasdaq
  • LTRN Nasdaq
  • Market Cap
  • MDCX 33.8M
  • LTRN 33.7M
  • IPO Year
  • MDCX N/A
  • LTRN 2020
  • Fundamental
  • Price
  • MDCX $2.83
  • LTRN $5.08
  • Analyst Decision
  • MDCX Strong Buy
  • LTRN Hold
  • Analyst Count
  • MDCX 1
  • LTRN 1
  • Target Price
  • MDCX $10.00
  • LTRN N/A
  • AVG Volume (30 Days)
  • MDCX 9.2K
  • LTRN 156.7K
  • Earning Date
  • MDCX 01-01-0001
  • LTRN 03-17-2025
  • Dividend Yield
  • MDCX N/A
  • LTRN N/A
  • EPS Growth
  • MDCX N/A
  • LTRN N/A
  • EPS
  • MDCX N/A
  • LTRN N/A
  • Revenue
  • MDCX N/A
  • LTRN N/A
  • Revenue This Year
  • MDCX N/A
  • LTRN N/A
  • Revenue Next Year
  • MDCX N/A
  • LTRN N/A
  • P/E Ratio
  • MDCX N/A
  • LTRN N/A
  • Revenue Growth
  • MDCX N/A
  • LTRN N/A
  • 52 Week Low
  • MDCX $1.80
  • LTRN $2.79
  • 52 Week High
  • MDCX $3.23
  • LTRN $11.99
  • Technical
  • Relative Strength Index (RSI)
  • MDCX N/A
  • LTRN 64.21
  • Support Level
  • MDCX N/A
  • LTRN $4.60
  • Resistance Level
  • MDCX N/A
  • LTRN $5.30
  • Average True Range (ATR)
  • MDCX 0.00
  • LTRN 0.61
  • MACD
  • MDCX 0.00
  • LTRN 0.06
  • Stochastic Oscillator
  • MDCX 0.00
  • LTRN 68.99

About MDCX Medicus Pharma Ltd. Common Stock

Medicus Pharma Ltd is a clinical-stage, multi-strategy holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA approved clinical trials.

About LTRN Lantern Pharma Inc.

Lantern Pharma Inc is an AI company transforming the cost, pace, and timeline of oncology drug discovery and development. Its proprietary AI and machine learning (ML) platform, RADR, uses oncology-focused data points and advanced ML algorithms to solve billion-dollar, real-world problems in cancer drug development. The group's growing pipeline of precision therapies has been accelerated using AI and input from world-class scientific advisors and collaborators.

Share on Social Networks: